{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:20:38Z","timestamp":1790000438414,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81571996"],"award-info":[{"award-number":["81571996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2017J07005"],"award-info":[{"award-number":["2017J07005"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2016J05201"],"award-info":[{"award-number":["2016J05201"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Projects in Science and Technology","award":["2018ZX09303005-002"],"award-info":[{"award-number":["2018ZX09303005-002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.antiviral.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T14:36:05Z","timestamp":1550932565000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A"],"prefix":"10.1016","volume":"164","author":[{"given":"Kaihang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6655-2463","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3074-1649","authenticated-orcid":false,"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.02.013_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1440-1746.2000.02006.x","article-title":"Hepatitis E: an overview and recent advances in clinical and laboratory research","volume":"15","author":"Aggarwal","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tips.2017.06.002","article-title":"An overview of novel adjuvants designed for improving vaccine efficacy","volume":"38","author":"Bonam","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2019.02.013_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.it.2017.10.002","article-title":"Improving vaccine and immunotherapy design using biomaterials","volume":"39","author":"Bookstaver","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib5","first-page":"195","article-title":"Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Broker","year":"2011","journal-title":"Biologicals J. Int. Assoc. Buddhist Stand."},{"key":"10.1016\/j.antiviral.2019.02.013_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14760584.2017.1306440","article-title":"An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators","volume":"16","author":"Chauhan","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2019.02.013_bib8","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.02.013_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.antiviral.2013.12.005","article-title":"Antiviral strategies for hepatitis E virus","volume":"102","author":"Debing","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.02.013_bib10","first-page":"21","article-title":"Vaccination against hepatitis B: the Heptavax-B and Recombivax-HB vaccines","volume":"9","author":"Diaz-Arnold","year":"1989","journal-title":"Dentistry"},{"key":"10.1016\/j.antiviral.2019.02.013_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2012.06673.x","article-title":"Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine","volume":"1263","author":"Gruber","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.02.013_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/cr.2015.34","article-title":"Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody","volume":"25","author":"Gu","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2019.02.013_bib13","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1128\/IAI.67.12.6375-6384.1999","article-title":"Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines","volume":"67","author":"Guttormsen","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2019.02.013_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/14712598.6.11.1223","article-title":"HPV vaccination with Gardasil: a breakthrough in women's health","volume":"6","author":"Hanna","year":"2006","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2019.02.013_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1099\/vir.0.83308-0","article-title":"Putative receptor-binding sites of hepatitis E virus","volume":"89","author":"He","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/323342","article-title":"Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody","volume":"184","author":"Kamboj","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.02.013_bib17","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","article-title":"A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates","volume":"23","author":"Li","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.02.013_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","article-title":"The development of a recombinant hepatitis E vaccine HEV 239","volume":"11","author":"Li","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.02.013_bib19","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2019.02.013_bib20","doi-asserted-by":"crossref","first-page":"18 11 11","DOI":"10.1002\/9780471729259.mc1801s36","article-title":"Progress in vaccine development","volume":"36","author":"Moyle","year":"2015","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.biotechadv.2017.03.005","article-title":"Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines","volume":"35","author":"Moyle","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.antiviral.2019.02.013_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2019.02.013_bib23","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.02.013_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.copbio.2017.03.018","article-title":"Bioengineering towards self-assembly of particulate vaccines","volume":"48","author":"Rehm","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6445-1_1","article-title":"Overview of vaccine adjuvants: introduction, history, and current status","volume":"1494","author":"Shah","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jfma.2015.02.003","article-title":"Hepatitis E: a disease of reemerging importance","volume":"114","author":"Sridhar","year":"2015","journal-title":"J. Formos. Med. Assoc. = Taiwan yi zhi"},{"key":"10.1016\/j.antiviral.2019.02.013_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12885-017-3098-7","article-title":"Enhanced and long term immunogenicity of a Her-2\/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant montanide","volume":"17","author":"Tobias","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.antiviral.2019.02.013_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.antiviral.2019.02.013_bib32","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2004.11.065","article-title":"Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein","volume":"23","author":"Zhang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.02.013_bib33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1406011","article-title":"Long-term efficacy of a hepatitis E vaccine","volume":"372","author":"Zhang","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.02.013_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jmv.1027","article-title":"Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein","volume":"64","author":"Zhang","year":"2001","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.02.013_bib35","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2217\/nnm-2016-0146","article-title":"A shared N-terminal hydrophobic tail for the formation of nanoparticulates","volume":"11","author":"Zhang","year":"2016","journal-title":"Nanomedicine"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218304571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218304571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T13:39:40Z","timestamp":1662989980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218304571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":31,"alternative-id":["S0166354218304571"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}